Popular decongestant used in cold medicines ineffective: USFDA panel

The panel vote could lead to the removal of oral phenylephrine, which is a major component of popular products like Benadryl, Advil and Tylenol, from the FDA's list of approved OTC ingredients, barring its sale in the United States.

Published On 2023-09-13 07:00 GMT   |   Update On 2023-10-12 11:44 GMT
Advertisement

United States: An outside panel of experts to the U.S. Food and Drug Administration on Tuesday refused to back the effectiveness of oral over-the-counter (OTC) medicines made with phenylephrine, an ingredient widely used in cold and cough syrups.

The panel unanimously voted against the effectiveness of orally administered phenylephrine as a nasal decongestant, adding that no more trials were required to prove otherwise.

Advertisement

The panel vote could lead to the removal of oral phenylephrine, which is a major component of popular products like Benadryl, Advil and Tylenol, from the FDA's list of approved OTC ingredients, barring its sale in the United States.

The FDA usually follows the recommendations of its expert panel but is not obligated to do so.

"The patient community requires and deserves medications that treat their symptoms safely and effectively and I don't believe that this medication does that," said Jennifer Schwartzott, one of the FDA panelists.

Kenvue, the maker of Tylenol, and GSK, which markets Advil, did not immediately respond to Reuters requests for comment.

Phenylephrine was substituted for pseudoephedrine in many non-prescription cold and allergy medicines after the latter was restricted amid reports of abuse.

Read also: 3 baby formula makers get USFDA warning letter to correct manufacturing process controls



Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News